MDM2 and p53 expression in DLBCL patients treated with R-CHOP
A. MDM2 and p53 expression in DLBCL patients with WT-p53 or MUT-p53
| . | Overall . | WT-p53 . | MUT-p53 . |
|---|---|---|---|
| Number of MDM2– patients | 285 | 216 | 69 |
| Number of MDM2+ patients | 193 | 156 | 37 |
| Mean MDM2 expression (% cells) | 22% | 24% | 17% |
| Number of p53– patients | 292 | 262 | 30 |
| Number of p53+ patients | 182 | 107 | 75 |
| Mean p53 expression (% cells) | 23% | 14% | 54% |
| . | Overall . | WT-p53 . | MUT-p53 . |
|---|---|---|---|
| Number of MDM2– patients | 285 | 216 | 69 |
| Number of MDM2+ patients | 193 | 156 | 37 |
| Mean MDM2 expression (% cells) | 22% | 24% | 17% |
| Number of p53– patients | 292 | 262 | 30 |
| Number of p53+ patients | 182 | 107 | 75 |
| Mean p53 expression (% cells) | 23% | 14% | 54% |